PMID- 23861542 OWN - NLM STAT- MEDLINE DCOM- 20140204 LR - 20211021 IS - 1937-9145 (Electronic) IS - 1945-0877 (Linking) VI - 6 IP - 284 DP - 2013 Jul 16 TI - Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression. PG - ra60 LID - 10.1126/scisignal.2003743 [doi] AB - Tumor necrosis factor-alpha (TNF-alpha) elicits its biological activities through activation of TNF receptor 1 (TNFR1, also known as p55) and TNFR2 (also known as p75). The activities of both receptors are required for the TNF-alpha-induced proinflammatory response. The adaptor protein TNFR-associated factor 2 (TRAF2) is critical for either p55- or p75-mediated activation of nuclear factor kappaB (NF-kappaB) and mitogen-activated protein kinase (MAPK) signaling, as well as for target gene expression. We identified nonmuscle myosin II (myosin) as a binding partner of p75. TNF-alpha-dependent signaling by p75 and induction of target gene expression persisted substantially longer in cells deficient in myosin regulatory light chain (MRLC; a component of myosin) than in cells replete in myosin. In resting endothelial cells, myosin was bound constitutively to the intracellular region of p75, a region that overlaps with the TRAF2-binding domain, and TNF-alpha caused the rapid dissociation of myosin from p75. At early time points after exposure to TNF-alpha, p75 activated Rho-associated kinase 1 (ROCK1). Inhibition of ROCK1 activity blocked TNF-alpha-dependent phosphorylation of MRLC and the dissociation of myosin from p75. ROCK1-dependent release of myosin was necessary for the TNF-alpha-dependent recruitment of TRAF2 to p75 and for p75-specific activation of NF-kappaB and MAPK signaling. Thus, our findings have revealed a previously uncharacterized, noncanonical regulatory function of myosin in cytokine signaling. FAU - Chandrasekharan, Unni M AU - Chandrasekharan UM AD - Department of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. FAU - Dechert, Lisa AU - Dechert L FAU - Davidson, Uchechukwu I AU - Davidson UI FAU - Waitkus, Matthew AU - Waitkus M FAU - Mavrakis, Lori AU - Mavrakis L FAU - Lyons, Katherine AU - Lyons K FAU - Beach, Jordan R AU - Beach JR FAU - Li, Xiaoxia AU - Li X FAU - Egelhoff, Thomas T AU - Egelhoff TT FAU - Fox, Paul L AU - Fox PL FAU - DiCorleto, Paul E AU - DiCorleto PE LA - eng GR - R01 GM050009/GM/NIGMS NIH HHS/United States GR - UL1 TR000439/TR/NCATS NIH HHS/United States GR - UL1TR000439/TR/NCATS NIH HHS/United States GR - P01 HL029582/HL/NHLBI NIH HHS/United States GR - HL29582/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130716 PL - United States TA - Sci Signal JT - Science signaling JID - 101465400 RN - 0 (NF-kappa B) RN - 0 (Receptors, Tumor Necrosis Factor, Type I) RN - 0 (Receptors, Tumor Necrosis Factor, Type II) RN - 0 (TNF Receptor-Associated Factor 2) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.11.1 (ROCK2 protein, human) RN - EC 2.7.11.1 (rho-Associated Kinases) RN - EC 3.6.1.- (Myosin Type II) SB - IM MH - Cytosol/*metabolism MH - Gene Expression Regulation/*physiology MH - Human Umbilical Vein Endothelial Cells/cytology/*metabolism MH - Humans MH - MAP Kinase Signaling System/*physiology MH - Myosin Type II/genetics/*metabolism MH - NF-kappa B/genetics/metabolism MH - Receptors, Tumor Necrosis Factor, Type I/genetics/metabolism MH - Receptors, Tumor Necrosis Factor, Type II/genetics/*metabolism MH - TNF Receptor-Associated Factor 2/genetics/metabolism MH - Tumor Necrosis Factor-alpha/genetics/metabolism MH - rho-Associated Kinases/genetics/metabolism PMC - PMC3837481 MID - NIHMS524745 EDAT- 2013/07/19 06:00 MHDA- 2014/02/05 06:00 PMCR- 2014/01/16 CRDT- 2013/07/18 06:00 PHST- 2013/07/18 06:00 [entrez] PHST- 2013/07/19 06:00 [pubmed] PHST- 2014/02/05 06:00 [medline] PHST- 2014/01/16 00:00 [pmc-release] AID - 6/284/ra60 [pii] AID - 10.1126/scisignal.2003743 [doi] PST - epublish SO - Sci Signal. 2013 Jul 16;6(284):ra60. doi: 10.1126/scisignal.2003743.